
Yeonji Kim
Articles
-
3 days ago |
outsourcedpharma.com | Xiaojun Liu |Yeonji Kim |Chris Brown |Jing Zhu |Louis Garguilo
By Xiaojun Liu, Yeonji Kim, Chris Brown, and Jing Zhu Recombinant adeno-associated virus (rAAV) vectors are pivotal in gene therapy due to their proven safety and efficacy for therapeutic gene delivery. However, low production yields and vector heterogeneity remain significant barriers to scalable, high-quality manufacturing.
-
3 days ago |
cellandgene.com | Xiaojun Liu |Yeonji Kim |Chris Brown |Jing Zhu
By Xiaojun Liu, Yeonji Kim, Chris Brown, and Jing Zhu Recombinant adeno-associated virus (rAAV) vectors are pivotal in gene therapy due to their proven safety and efficacy for therapeutic gene delivery. However, low production yields and vector heterogeneity remain significant barriers to scalable, high-quality manufacturing.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →